Mesothelin-positive Advanced Refractory Solid Tumors

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Mesothelin-positive Advanced Refractory Solid Tumors trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1

NCT05410717

CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors

This study is an open, exploratory clinical study to evaluate the safety and preliminary efficacy of Claudin6, GPC3, Mesothelin, or AXL targeting CAR-NK cells i…

China200 participantsStarted 2022-06-01

Treatment: Claudin6, GPC3, Mesothelin, or AXL targeting CAR-NK cells

All recent trials (2 shown)

WithdrawnPhase 1

NCT05531708

Exploratory Study of Novel MSLN CAR-T Cell Therapy in Patients With MSLN-positive Advanced Refractory Solid Tumors

This is a single-arm, open-label, exploratory clinical study to evaluate the safety and efficacy of novel Mesothelin CAR-T in patients with Mesothelin-positive…

China0Started 2021-04-02

Treatment: Anti-mesothelin CAR-T cells, Fludarabine